Evidence map

ArticleDiabetes2025

Predicting Sustained Benefit From Tirzepatide in SURPASS-4: Who Benefits and Why?

Miroslava Varadinova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40971612